Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Novik · SciRah

Researcher profile · Semantic Scholar

L. Novik

Share profile

L. Novik — researcher profile on SciRah

h-index: 20
Works: 39
Citations: 4,293

Most-cited papers

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
K. Corbett, Barbara Flynn, K. Foulds, J. Francica +70 more
2020New England Journal of Medicine989 citations Open access
Semantic Scholar
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
R. Seder, Lee-Jah Chang, Mary E. Enama, Kathryn L. Zephir +38 more
2013Science779 citations
Semantic Scholar
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
A. Ishizuka, K. Lyke, A. Dezure, Andrea A. Berry +52 more
2016Nature Medicine347 citations Open access
Semantic Scholar
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.
Andrew T. Catanzaro, R. Koup, M. Roederer, R. Bailer +15 more
2006Journal of Infectious Diseases335 citations Open access
Semantic Scholar
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
M. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito, Zong-Hui Hu +86 more
2017The Lancet269 citations Open access
Semantic Scholar
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
K. Lyke, A. Ishizuka, A. Berry, S. Chakravarty +35 more
2017Proceedings of the National Academy of Sciences of the United States of America236 citations Open access
Semantic Scholar
Chimpanzee Adenovirus Vector Ebola Vaccine
J. Ledgerwood, A. Dezure, Daphne A. Stanley, Emily E. Coates +23 more
2017New England Journal of Medicine222 citations Open access
Semantic Scholar
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
Ling-Shu Wang, Tongqing Zhou, Yi Zhang, E. Yang +54 more
2021Science179 citations Open access
Semantic Scholar
Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
R. Koup, M. Roederer, L. Lamoreaux, J. Fischer +9 more
2010PLoS ONE145 citations Open access
Semantic Scholar
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
Katherine V. Houser, Grace L. Chen, Cristina A Carter, M. Crank +70 more
2022Nature Medicine137 citations Open access
Semantic Scholar
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114: A Phase 1 Trial of a Therapeutic Monoclonal Antibody Targeting Ebola Virus Glycoprotein
M. Gaudinski, Emily E. Coates, L. Novik, A. Widge +57 more
2019The Lancet98 citations Open access
Semantic Scholar
Safety and pharmacokinetics of broadly neutralizing human monoclonal antibody VRC07–523LS in healthy adults: A phase 1 dose-escalation clinical trial
M. Gaudinski, Katherine V. Houser, N. Doria-Rose, Grace L. Chen +60 more
2019The Lancet HIV92 citations Open access
Semantic Scholar
AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific TH1 response with a diverse TCR repertoire
Phillip A. Swanson, M. Padilla, W. Hoyland, K. McGlinchey +65 more
2021Science Translational Medicine88 citations Open access
Semantic Scholar
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
J. Casazza, Evan M. Cale, S. Narpala, G. Yamshchikov +82 more
2022Nature Medicine80 citations Open access
Semantic Scholar
Corrigendum: Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1
A. Ishizuka, K. Lyke, A. Dezure, Andrea A. Berry +52 more
2016Nature Medicine48 citations Open access
Semantic Scholar
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial
Katherine V. Houser, M. Gaudinski, Myra Happe, S. Narpala +41 more
2022EClinicalMedicine35 citations Open access
Semantic Scholar
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
Ling-Shu Wang, Tongqing Zhou, Yi Zhang, E. Yang +43 more
2021bioRxiv33 citations Open access
Semantic Scholar
Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011)
Mary E. Enama, J. Ledgerwood, L. Novik, M. Nason +8 more
2014PLoS ONE27 citations Open access
Semantic Scholar
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
Noemia S. Lima, Maryam Musayev, T. Johnston, Danielle A. Wagner +52 more
2022Nature Communications26 citations Open access
Semantic Scholar
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
J. Casazza, Amelia R Hofstetter, Pamela J. M. Costner, Lasonji Holman +102 more
2024npj Vaccines22 citations Open access
Semantic Scholar
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide
Shui-Shu Wang, Flavio Matassoli, Bao-Shan Zhang, Tracy Liu +32 more
2023Cell Reports17 citations Open access
Semantic Scholar
Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine
A. V. Moisseeva, I. L. Marichev, N. A. Biloschitchkay, K. I. Pavlenko +5 more
2008Journal of Viral Hepatitis16 citations
Semantic Scholar
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
Myra Happe, Amelia R Hofstetter, Jing Wang, G. Yamshchikov +93 more
2024npj Vaccines15 citations Open access
Semantic Scholar
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)
M. Crank, Eleanor M. P. Wilson, L. Novik, Mary E. Enama +11 more
2016PLoS ONE15 citations Open access
Semantic Scholar
Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.
J. Ledgerwood, A. Dezure, Daphne A. Stanley, L. Novik +23 more
2015New England Journal of Medicine15 citations
Semantic Scholar
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
Myra Happe, Rebecca M. Lynch, C. Fichtenbaum, S. Heath +33 more
2025JCI Insight11 citations Open access
Semantic Scholar
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
N. Lima, Maryam Musayev, T. Johnston, Danielle A. Wagner +50 more
2022bioRxiv11 citations Open access
Semantic Scholar
Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial
Uzma N. Sarwar, L. Novik, Mary E. Enama, Sarah A. Plummer +8 more
2014PLoS ONE7 citations Open access
Semantic Scholar
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial
Aurélie Ploquin, R. Mason, Lasonji Holman, Myra Happe +47 more
2026Nature Medicine6 citations Open access
Semantic Scholar
Clinical outcomes and immune responses to SARS‐CoV‐2 vaccination in severe aplastic anaemia
Roma V. Rajput, Xiao-Yang Ma, Kristin Boswell, M. Gaudinski +23 more
2022British Journal of Haematology3 citations Open access
Semantic Scholar
Rational Design of Multiclade Coronavirus Spike Immunodominant Domain Nanoparticles to Elicit Broad Antibody Responses
Christian K. O. Dzuvor, Sydney P. Moak, Lindsay R. McManus, Abigail Thomas +10 more
2025bioRxiv2 citations Open access
Semantic Scholar
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114: A Phase 1 Trial of a Therapeutic Monoclonal Antibody Targeting Ebola Virus Glycoprotein
M. Gaudinski, Emily E. Coates, L. Novik, A. Widge +30 more
20191 citations
Semantic Scholar
P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)
J. Ledgerwood, L. Novik, Mary E. Enama, Ingelise J. Gordon +8 more
2009Retrovirology1 citations Open access
Semantic Scholar
Winds, Sand, Companions, humans: Attuning bodies for post-antropocentric Worlds
Eliana Sánchez-Aldana, L. Novik, Pablo Hermansen
2026Proceedings of DRS0 citations
Semantic Scholar
Rational Design of Multiclade Coronavirus Spike Immunodominant Domain Nanoparticles to Elicit Broad Antibody Responses
Christian K. O. Dzuvor, Sydney P. Moak, Lindsay R. McManus, Abigail Thomas +10 more
2025Research Square0 citations
Semantic Scholar
Novel Lineages of SARS-CoV-2 Receptor Binding Domain Monoclonal Antibodies Demonstrate Broad and Potent Neutralization Across SARS-CoV-2 and Other Sarbecoviruses 9206
Quenelle W. McKim, Ling-Shu Wang, Tong-Qing Zhou, Maryam Musayev +20 more
2025Journal of Immunology0 citations
Semantic Scholar
Early Innate and Adaptive Immune Responses to Investigational Human Immunodeficiency Virus (HIV)-1 Vaccines (VRC 016 study)
Uzma N. Sarwar, L. Novik, Mary E. Enama, Douglas M. Herrin +4 more
20150 citations Open access
Semantic Scholar
P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults
Mary E. Enama, L. Novik, Lasonji Holman, Ingelise J. Gordon +3 more
2009Retrovirology0 citations Open access
Semantic Scholar
A moda argentina e a cultura popular
L. Novik
20080 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Ingelise J. Gordon×28
Invite
Ingelise J. Gordon — researcher profile on SciRah
J. Ledgerwood×26
Invite
J. Ledgerwood — researcher profile on SciRah
J. Mascola×23
Invite
J. Mascola — researcher profile on SciRah
B. Graham×22
Invite
B. Graham — researcher profile on SciRah

×21

Invite

Lasonji Holman — researcher profile on SciRah

Invite

R. Koup — researcher profile on SciRah

A. McDermott×17

Invite

A. McDermott — researcher profile on SciRah

M. Gaudinski×16

Invite

M. Gaudinski — researcher profile on SciRah

Mary E. Enama×15

Invite

Mary E. Enama — researcher profile on SciRah

C. S. Hendel×15

Invite

C. S. Hendel — researcher profile on SciRah

Invite

R. Bailer — researcher profile on SciRah

Invite

M. Nason — researcher profile on SciRah